It’s not too late to submit a poster for the Biosimilars to Biobetters - the paths forward event!
http://www.regonline.co.uk/builder/site/Default.aspx?EventID=1100925
Abstracts for poster presentation only can be submitted up to two weeks before the event. Please note that there will be a best poster prize.
Abstracts can be submitted to: abstracts@euroscicon.com
When: Thursday 16th May 2013
Where:
The Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage
Hertfordshire
SG1 2FX
United Kingdom
What: Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. However, as these biosimilar markets are captured how we manage the life cycle of these products and target specific patient and commercial benefits to maximise our product development strategies becomes increasingly important. This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place. This event has CPD accreditation.
This event is part of the 2013 Euroscicon BioTherapeutics Week, to find out more see www.biotherapeutics2013.com
Tags: automation, Biobetter, biobetters, Biologicals, biopharmaceutical, bioreactor, Biosimilar, Biosimilarity, Biosimilars, cell line, Characterisation, characterization, chromatography, CMC, Comparability, CTD, drug delivery, enabling, EU, glycan, mass spectrometry, monoclonal antibodies, next generation biologics, post-translational modifications, Process Development, Product registration, Regulatory, Similarity, technologies, variants
Follow Us!